Toll Free: 1-888-928-9744

2017-2022 Global and Japan mRNA Vaccines & Therapeutics Market Analysis Report

Published: Aug 9, 2017 | Pages: 116 | Publisher: JP Research | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The global mRNA Vaccines & Therapeutics market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022.

Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2017, with a CAGR of xx%.

This report, with focus on top players in the global and Japan, studies the mRNA Vaccines & Therapeutics market's development status and future trend in the global and Japan. It splits mRNA Vaccines & Therapeutics market by type and by applications to fully and deeply research and reveal market profile and prospect.

The major players include
    Argos Therapeutics (U.S.)
    AstraZeneca (UK)
    Bayer AG (Germany)
    BioNTech (Germany)
    Boehringer Ingelheim (Germany)
    CRISPR Therapeutics (Switzerland)
    CureVac (Germany)
    ETheRNA immunotherapies (Belgium)
    Ethris (Germany)
    GlaxoSmithKline Vaccines (UK)
    In-Cell-Art (France)
    Intellia Therapeutics (U.S.)
    Janssen (Belhium)
    Kernal Biologics (U.S.)
    MaxCyte (U.S.)
    Moderna Therapeutics (U.S.)
    Novartis (U.S.)
    PhaseRx (U.S.)
    Precision NanoSystems (Canada)
    RaNa Therapeutics (U.S.)

Geographically, this report splits the Global market into the following regions:
    Asia Pacific
        Japan
            Tokyo
            Yokohama
            Osaka
            Nagoya
            Others
        China
        Korea
        India
        Others
    Europe
        France
        Germany
        United Kingdom
        Italy
        Russia
        Others
    North America
        United States
        Canada
    Latin America
        Brazil
        Mexico
        Others
    Southeast Asia
        Singapore
        Malaysia
        Vietnam
        Myanmar
        Thailand
        Indonesia
        Philippines
        Others
    Middle East & Africa
        Saudi Arabia
        Iran
        UAE
        Turkey
        Israel
        Egypt
        South Africa
        Others

On the basis of product, the mRNA Vaccines & Therapeutics market is primarily split into
By Cancer Vaccines
    Standardized preselected
    Individualized shared antigens
    Individualized neoantigens
By Infectious Disease Vaccines
    Prophylactic vaccines
    Therapeutic vaccines
    Synthetic self-amplifying mRNA vaccines for pandemic outbreaks
By In vivo Therapeutics
    Therapeutic proteins
    Therapeutic antibodies
By Gene Editing
    Ex vivo gene editing of gene defects
    In vivo gene editing of gene defects
    Ex vivo gene editing of autologous and allogeneic T-cells

Key Applications
    Hospital
    Clinic
    Others


 Table of Contents

2017-2022 Global and Japan mRNA Vaccines & Therapeutics Market Analysis Report
1 mRNA Vaccines & Therapeutics Overview
    1.1 Product Overview and Scope of mRNA Vaccines & Therapeutics
    1.2 Global and Japan mRNA Vaccines & Therapeutics Market by Applications/End Users
        1.2.1 Japan mRNA Vaccines & Therapeutics Sales (K Units) and Market Share Comparison by Applications (2012-2017)
            1.2.1.1 Japan mRNA Vaccines & Therapeutics Sales (K Units) and Market Share by Applications (2012-2017)
            1.2.1.2 Japan mRNA Vaccines & Therapeutics Sales Growth Rate (%) by Applications (2012-2017)
            1.2.1.3 Market Drivers and Opportunities
        1.2.2 Japan mRNA Vaccines & Therapeutics Sales (K Units) and Market Share Comparison by Applications (2012-2017)
        1.2.3 Global mRNA Vaccines & Therapeutics Sales by Application (2012-2017)
            1.2.3.1 Global mRNA Vaccines & Therapeutics Sales (K Units) and Market Share by Applications (2012-2017)
            1.2.3.2 Global mRNA Vaccines & Therapeutics Sales Growth Rate (%) by Applications (2012-2017)
            1.2.3.3 Market Drivers and Opportunities
        1.2.4 Global mRNA Vaccines & Therapeutics Sales (K Units) and Market Share Comparison by Applications (2012-2017)
        1.2.5 Hospital
        1.2.6 Clinic
        1.2.7 Others
    1.3 Global and Japan Market Size (Sales and Revenue) of mRNA Vaccines & Therapeutics (2012-2017)
        1.3.1 Japan Market Size (Sales and Revenue) of mRNA Vaccines & Therapeutics (2012-2017)
            1.3.1.1 Japan mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%) (2012-2017)
            1.3.1.2 Japan mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
        1.3.2 Global Market Size (Sales and Revenue) of mRNA Vaccines & Therapeutics (2012-2017)
            1.3.2.1 Global mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%) (2012-2017)
            1.3.2.2 Global mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
    1.4 Global and Japan Classification of mRNA Vaccines & Therapeutics by Cancer Vaccines
        1.4.1 Japan mRNA Vaccines & Therapeutics Sales (K Units) and Market Share by Cancer Vaccines (2012-2017)
        1.4.2 Global mRNA Vaccines & Therapeutics Sales (K Units) and Market Share by Cancer Vaccines (2012-2017)
        1.4.3 Japan mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by Cancer Vaccines (2012-2017)
        1.4.4 Global mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by Cancer Vaccines (2012-2017)
        1.4.5 Japan mRNA Vaccines & Therapeutics Price (USD/Unit) by Cancer Vaccines (2012-2017)
        1.4.6 Global mRNA Vaccines & Therapeutics Price (USD/Unit) by Cancer Vaccines (2012-2017)
        1.4.7 Japan mRNA Vaccines & Therapeutics Sales Growth Rate (%) by Cancer Vaccines (2012-2017)
        1.4.8 Global mRNA Vaccines & Therapeutics Sales Growth Rate (%) by Cancer Vaccines (2012-2017)
        1.4.9 Standardized preselected
        1.4.10 Individualized shared antigens
        1.4.11 Individualized neoantigens
    1.5 Global and Japan Classification of mRNA Vaccines & Therapeutics by Infectious Disease Vaccines
        1.5.1 Japan mRNA Vaccines & Therapeutics Sales (K Units) and Market Share by Infectious Disease Vaccines (2012-2017)
        1.5.2 Global mRNA Vaccines & Therapeutics Sales (K Units) and Market Share by Infectious Disease Vaccines (2012-2017)
        1.5.3 Japan mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by Infectious Disease Vaccines (2012-2017)
        1.5.4 Global mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by Infectious Disease Vaccines (2012-2017)
        1.5.5 Japan mRNA Vaccines & Therapeutics Price (USD/Unit) by Infectious Disease Vaccines (2012-2017)
        1.5.6 Global mRNA Vaccines & Therapeutics Price (USD/Unit) by Infectious Disease Vaccines (2012-2017)
        1.5.7 Japan mRNA Vaccines & Therapeutics Sales Growth Rate (%) by Infectious Disease Vaccines (2012-2017)
        1.5.8 Global mRNA Vaccines & Therapeutics Sales Growth Rate (%) by Infectious Disease Vaccines (2012-2017)
        1.5.9 Prophylactic vaccines
        1.5.10 Therapeutic vaccines
        1.5.11 Synthetic self-amplifying mRNA vaccines for pandemic outbreaks
    1.6 Global and Japan Classification of mRNA Vaccines & Therapeutics by In vivo Therapeutics
        1.6.1 Japan mRNA Vaccines & Therapeutics Sales (K Units) and Market Share by In vivo Therapeutics (2012-2017)
        1.6.2 Global mRNA Vaccines & Therapeutics Sales (K Units) and Market Share by In vivo Therapeutics (2012-2017)
        1.6.3 Japan mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by In vivo Therapeutics (2012-2017)
        1.6.4 Global mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by In vivo Therapeutics (2012-2017)
        1.6.5 Japan mRNA Vaccines & Therapeutics Price (USD/Unit) by In vivo Therapeutics (2012-2017)
        1.6.6 Global mRNA Vaccines & Therapeutics Price (USD/Unit) by In vivo Therapeutics (2012-2017)
        1.6.7 Japan mRNA Vaccines & Therapeutics Sales Growth Rate (%) by In vivo Therapeutics (2012-2017)
        1.6.8 Global mRNA Vaccines & Therapeutics Sales Growth Rate (%) by In vivo Therapeutics (2012-2017)
        1.6.9 Therapeutic proteins
        1.6.10 Therapeutic antibodies
    1.7 Global and Japan Classification of mRNA Vaccines & Therapeutics by Gene Editing
        1.7.1 Japan mRNA Vaccines & Therapeutics Sales (K Units) and Market Share by Gene Editing (2012-2017)
        1.7.2 Global mRNA Vaccines & Therapeutics Sales (K Units) and Market Share by Gene Editing (2012-2017)
        1.7.3 Japan mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by Gene Editing (2012-2017)
        1.7.4 Global mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by Gene Editing (2012-2017)
        1.7.5 Japan mRNA Vaccines & Therapeutics Price (USD/Unit) by Gene Editing (2012-2017)
        1.7.6 Global mRNA Vaccines & Therapeutics Price (USD/Unit) by Gene Editing (2012-2017)
        1.7.7 Japan mRNA Vaccines & Therapeutics Sales Growth Rate (%) by Gene Editing (2012-2017)
        1.7.8 Global mRNA Vaccines & Therapeutics Sales Growth Rate (%) by Gene Editing (2012-2017)
        1.7.9 Ex vivo gene editing of gene defects
        1.7.10 In vivo gene editing of gene defects
        1.7.11 Ex vivo gene editing of autologous and allogeneic T-cells

2 Global and Japan mRNA Vaccines & Therapeutics Market Competition by Players/Manufacturers
    2.1 Japan mRNA Vaccines & Therapeutics Market Competition by Players/Manufacturers
    2.1.1 Japan mRNA Vaccines & Therapeutics Sales and Market Share of Key Players/Manufacturers (2012-2017)
    2.1.2 Japan mRNA Vaccines & Therapeutics Revenue and Share by Players/Manufacturers (2012-2017)
    2.1.3 Japan mRNA Vaccines & Therapeutics Average Price (USD/Unit) by Players/Manufacturers (2012-2017)
    2.1.4 Japan mRNA Vaccines & Therapeutics Market Competitive Situation and Trends
        2.1.4.1 Japan mRNA Vaccines & Therapeutics Market Concentration Rate
        2.1.4.2 Japan mRNA Vaccines & Therapeutics Market Share of Top 3 and Top 5 Players/Manufacturers
        2.1.4.3 Mergers & Acquisitions, Expansion in Japan Market
    2.1.5 Japan Players/Manufacturers mRNA Vaccines & Therapeutics Manufacturing Base Distribution, Sales Area, Product Types
    2.2 Global mRNA Vaccines & Therapeutics Market Competition by Players/Manufacturers
    2.2.1 Global mRNA Vaccines & Therapeutics Sales and Market Share of Key Players/Manufacturers (2012-2017)
    2.2.2 Global mRNA Vaccines & Therapeutics Revenue and Share by Players/Manufacturers (2012-2017)
    2.2.3 Global mRNA Vaccines & Therapeutics Average Price (USD/Unit) by Players/Manufacturers (2012-2017)
    2.2.4 Global mRNA Vaccines & Therapeutics Market Competitive Situation and Trends
        2.2.4.1 Global mRNA Vaccines & Therapeutics Market Concentration Rate
        2.2.4.2 Global mRNA Vaccines & Therapeutics Market Share of Top 3 and Top 5 Players/Manufacturers
        2.2.4.3 Mergers & Acquisitions, Expansion in Global Market
    2.2.5 Global Players/Manufacturers mRNA Vaccines & Therapeutics Manufacturing Base Distribution, Sales Area, Product Types

3 Global and Japan mRNA Vaccines & Therapeutics Sales and Revenue by Regions (2012-2017)
    3.1 Asia Pacific mRNA Vaccines & Therapeutics Sales and Revenue by Regions (2012-2017)
        3.1.1 Japan mRNA Vaccines & Therapeutics Sales and Revenue  (2012-2017)
            3.1.1.1 Japan mRNA Vaccines & Therapeutics Sales (K Units) and Market Share  (2012-2017)
            3.1.1.2 Japan mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.1.1.3 Japan mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
        3.1.2 China mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.1.2.1 China mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.1.2.2 China mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.1.2.3 China mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
        3.1.3 Korea mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.1.3.1 Korea mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.1.3.2 Korea mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.1.3.3 Korea mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
        3.1.4 India mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.1.4.1 India mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.1.4.2 India mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.1.4.3 India mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
        3.1.5 Others mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.1.5.1 Others mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.1.5.2 Others mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.1.5.3 Others mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
    3.2 Europe mRNA Vaccines & Therapeutics Sales and Revenue by Regions (2012-2017)
        3.2.1 France mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.2.1.1 France mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.2.1.2 France mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.2.1.3 France mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
        3.2.2 Germany mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.2.2.1 Germany mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.2.2.2 Germany mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.2.2.3 Germany mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
        3.2.3 United Kingdom mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.2.3.1 United Kingdom mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.2.3.2 United Kingdom mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.2.3.3 United Kingdom mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
        3.2.4 Italy mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.2.4.1 Italy mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.2.4.2 Italy mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.2.4.3 Italy mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
        3.2.5 Russia mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.2.5.1 Russia mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.2.5.2 Russia mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.2.5.3 Russia mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
        3.2.6 Others mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.2.6.1 Others mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.2.6.2 Others mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.2.6.3 Others mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
    3.3 North America mRNA Vaccines & Therapeutics Sales and Revenue by Regions (2012-2017)
        3.3.1 United States mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.3.1.1 United States mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.3.1.2 United States mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.3.1.3 United States mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
        3.3.2 Canada mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.3.2.1 Canada mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.3.2.2 Canada mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.3.2.3 Canada mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
    3.4 Latin America mRNA Vaccines & Therapeutics Sales and Revenue by Regions (2012-2017)
        3.4.1 Brazil mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.4.1.1 Brazil mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.4.1.2 Brazil mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.4.1.3 Brazil mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
        3.4.2 Mexico mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.4.2.1 Mexico mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.4.2.2 Mexico mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.4.2.3 Mexico mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
        3.4.3 Others mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.4.3.1 Others mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.4.3.2 Others mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.4.3.3 Others mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
    3.5 Southeast Asia mRNA Vaccines & Therapeutics Sales and Revenue by Regions (2012-2017)
        3.5.1 Singapore mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.5.1.1 Singapore mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.5.1.2 Singapore mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.5.1.3 Singapore mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
        3.5.2 Malaysia mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.5.2.1 Malaysia mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.5.2.2 Malaysia mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.5.2.3 Malaysia mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
        3.5.3 Vietnam mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.5.3.1 Vietnam mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.5.3.2 Vietnam mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.5.3.3 Vietnam mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
        3.5.4 Myanmar mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.5.4.1 Myanmar mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.5.4.2 Myanmar mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.5.4.3 Myanmar mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
        3.5.5 Thailand mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.5.5.1 Thailand mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.5.5.2 Thailand mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.5.5.3 Thailand mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
        3.5.6 Indonesia mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.5.6.1 Indonesia mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.5.6.2 Indonesia mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.5.6.3 Indonesia mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
        3.5.7 Philippines mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.5.7.1 Philippines mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.5.7.2 Philippines mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.5.7.3 Philippines mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
        3.5.8 Others mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.5.8.1 Others mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.5.8.2 Others mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.5.8.3 Others mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
    3.6 Middle East & Africa mRNA Vaccines & Therapeutics Sales and Revenue by Regions (2012-2017)
        3.6.1 Saudi Arabia mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.6.1.1 Saudi Arabia mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.6.1.2 Saudi Arabia mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.6.1.3 Saudi Arabia mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
        3.6.2 Iran mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.6.2.1 Iran mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.6.2.2 Iran mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.6.2.3 Iran mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
        3.6.3 UAE mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.6.3.1 UAE mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.6.3.2 UAE mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.6.3.3 UAE mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
        3.6.4 Turkey mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.6.4.1 Turkey mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.6.4.2 Turkey mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.6.4.3 Turkey mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
        3.6.5 Israel mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.6.5.1 Israel mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.6.5.2 Israel mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.6.5.3 Israel mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
        3.6.6 Egypt mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.6.6.1 Egypt mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.6.6.2 Egypt mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.6.6.3 Egypt mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
        3.6.7 South Africa mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.6.7.1 South Africa mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.6.7.2 South Africa mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.6.7.3 South Africa mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)
        3.6.8 Others mRNA Vaccines & Therapeutics Sales and Revenue (2012-2017)
            3.6.8.1 Others mRNA Vaccines & Therapeutics Sales (K Units) and Market Share (2012-2017)
            3.6.8.2 Others mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share (2012-2017)
            3.6.8.3 Others mRNA Vaccines & Therapeutics Price (USD/Unit)(2012-2017)

4 Global and Japan mRNA Vaccines & Therapeutics Players/Manufacturers Profiles and Sales Data
    4.1 Argos Therapeutics (U.S.)
        4.1.1 Company Basic Information, Manufacturing Base and Competitors
        4.1.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
            4.1.2.1 Product A
            4.1.2.2 Product B
        4.1.3 Argos Therapeutics (U.S.) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        4.1.4 Main Business/Business Overview
    4.2 AstraZeneca (UK)
        4.2.1 Company Basic Information, Manufacturing Base and Competitors
        4.2.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
            4.2.2.1 Product A
            4.2.2.2 Product B
        4.2.3 AstraZeneca (UK) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        4.2.4 Main Business/Business Overview
    4.3 Bayer AG (Germany)
        4.3.1 Company Basic Information, Manufacturing Base and Competitors
        4.3.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
            4.3.2.1 Product A
            4.3.2.2 Product B
        4.3.3 Bayer AG (Germany) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        4.3.4 Main Business/Business Overview
    4.4 BioNTech (Germany)
        4.4.1 Company Basic Information, Manufacturing Base and Competitors
        4.4.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
            4.4.2.1 Product A
            4.4.2.2 Product B
        4.4.3 BioNTech (Germany) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        4.4.4 Main Business/Business Overview
    4.5 Boehringer Ingelheim (Germany)
        4.5.1 Company Basic Information, Manufacturing Base and Competitors
        4.5.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
            4.5.2.1 Product A
            4.5.2.2 Product B
        4.5.3 Boehringer Ingelheim (Germany) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        4.5.4 Main Business/Business Overview
    4.6 CRISPR Therapeutics (Switzerland)
        4.6.1 Company Basic Information, Manufacturing Base and Competitors
        4.6.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
            4.6.2.1 Product A
            4.6.2.2 Product B
        4.6.3 CRISPR Therapeutics (Switzerland) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        4.6.4 Main Business/Business Overview
    4.7 CureVac (Germany)
        4.7.1 Company Basic Information, Manufacturing Base and Competitors
        4.7.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
            4.7.2.1 Product A
            4.7.2.2 Product B
        4.7.3 CureVac (Germany) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        4.7.4 Main Business/Business Overview
    4.8 ETheRNA immunotherapies (Belgium)
        4.8.1 Company Basic Information, Manufacturing Base and Competitors
        4.8.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
            4.8.2.1 Product A
            4.8.2.2 Product B
        4.8.3 ETheRNA immunotherapies (Belgium) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        4.8.4 Main Business/Business Overview
    4.9 Ethris (Germany)
        4.9.1 Company Basic Information, Manufacturing Base and Competitors
        4.9.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
            4.9.2.1 Product A
            4.9.2.2 Product B
        4.9.3 Ethris (Germany) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        4.9.4 Main Business/Business Overview
    4.10 GlaxoSmithKline Vaccines (UK)
        4.10.1 Company Basic Information, Manufacturing Base and Competitors
        4.10.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
            4.10.2.1 Product A
            4.10.2.2 Product B
        4.10.3 GlaxoSmithKline Vaccines (UK) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
        4.10.4 Main Business/Business Overview
    4.11 In-Cell-Art (France)
    4.12 Intellia Therapeutics (U.S.)
    4.13 Janssen (Belhium)
    4.14 Kernal Biologics (U.S.)
    4.15 MaxCyte (U.S.)
    4.16 Moderna Therapeutics (U.S.)
    4.17 Novartis (U.S.)
    4.18 PhaseRx (U.S.)
    4.19 Precision NanoSystems (Canada)
    4.20 RaNa Therapeutics (U.S.)

5 mRNA Vaccines & Therapeutics Manufacturing Cost Analysis
    5.1 mRNA Vaccines & Therapeutics Key Raw Materials Analysis
        5.1.1 Key Raw Materials
        5.1.2 Price Trend of Key Raw Materials
        5.1.3 Key Suppliers of Raw Materials
        5.1.4 Market Concentration Rate of Raw Materials
    5.2 Proportion of Manufacturing Cost Structure
        5.2.1 Raw Materials
        5.2.2 Labor Cost
        5.2.3 Manufacturing Expenses
    5.3 Manufacturing Process Analysis of mRNA Vaccines & Therapeutics

6 Industrial Chain, Sourcing Strategy and Downstream Buyers
    6.1 mRNA Vaccines & Therapeutics Industrial Chain Analysis
    6.2 Upstream Raw Materials Sourcing
    6.3 Raw Materials Sources of mRNA Vaccines & Therapeutics Major Players/Manufacturers in 2016
    6.4 Downstream Buyers

7 Marketing Strategy Analysis, Distributors/Traders
    7.1 Marketing Channel
        7.1.1 Direct Marketing
        7.1.2 Indirect Marketing
        7.1.3 Marketing Channel Development Trend
    7.2 Market Positioning
        7.2.1 Pricing Strategy
        7.2.2 Brand Strategy
        7.2.3 Target Client
    7.3 Distributors/Traders List

8 Market Effect Factors Analysis
    8.1 Technology Progress/Risk
        8.1.1 Substitutes Threat
        8.1.2 Technology Progress in Related Industry
    8.2 Consumer Needs/Customer Preference Change
    8.3 Economic/Political Environmental Change

9 Global and Japan mRNA Vaccines & Therapeutics Market Size (Sales and Revenue) Forecast (2017-2022)
    9.1 Global and Japan mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD) Forecast (2017-2022)
    9.2 Global and Japan mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Type (2017-2022)
        9.2.1 by Cancer Vaccines
        9.2.2 by Infectious Disease Vaccines
        9.2.3 by In vivo Therapeutics
        9.2.4 by Gene Editing
    9.3 Global and Japan mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Application (2017-2022)
    9.4 Global and Japan mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Regions (2017-2022)

10 Research Findings and Conclusion

11 Methodology and Data Source
    11.1 Methodology/Research Approach
        11.1.1 Research Programs/Design
        11.1.2 Market Size Estimation
        11.1.3 Market Breakdown and Data Triangulation
    11.2 Data Source
        11.2.1 Secondary Sources
        11.2.2 Primary Sources
    11.3 Disclaimer
    11.4 Author List


List of Tables and Figures

    Figure Product Picture of mRNA Vaccines & Therapeutics
    Table Japan mRNA Vaccines & Therapeutics Sales (Million Units) Comparison by Applications (2012-2017)
    Figure Japan Sales Market Share (%) of mRNA Vaccines & Therapeutics by Applications in 2016
    Table Global mRNA Vaccines & Therapeutics Sales (Million Units) Comparison by Applications (2012-2017)
    Figure Global Sales Market Share (%) of mRNA Vaccines & Therapeutics by Applications in 2016
    Figure Hospital Examples
    Table Key Downstream Customer in Hospital
    Figure Clinic Examples
    Table Key Downstream Customer in Clinic
    Figure Others Examples
    Table Key Downstream Customer in Others
    Figure Standardized preselected Product Picture
    Figure Individualized shared antigens Product Picture
    Figure Individualized neoantigens Product Picture
    Figure Prophylactic vaccines Product Picture
    Figure Therapeutic vaccines Product Picture
    Figure Synthetic self-amplifying mRNA vaccines for pandemic outbreaks Product Picture
    Figure Therapeutic proteins Product Picture
    Figure Therapeutic antibodies Product Picture
    Figure Ex vivo gene editing of gene defects Product Picture
    Figure In vivo gene editing of gene defects Product Picture
    Figure Ex vivo gene editing of autologous and allogeneic T-cells Product Picture
    Table Argos Therapeutics (U.S.) Basic Information List
    Table Argos Therapeutics (U.S.) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Table Argos Therapeutics (U.S.) mRNA Vaccines & Therapeutics Sales Growth Rate (%)(2012-2017)
    Table Argos Therapeutics (U.S.) mRNA Vaccines & Therapeutics Sales Market Share (%) in Japan (2012-2017)
    Figure Argos Therapeutics (U.S.) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Japan (2012-2017)
    Table AstraZeneca (UK) Basic Information List
    Table AstraZeneca (UK) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Table AstraZeneca (UK) mRNA Vaccines & Therapeutics Sales Growth Rate (%)(2012-2017)
    Table AstraZeneca (UK) mRNA Vaccines & Therapeutics Sales Market Share (%) in Japan (2012-2017)
    Figure AstraZeneca (UK) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Japan (2012-2017)
    Table Bayer AG (Germany) Basic Information List
    Table Bayer AG (Germany) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Table Bayer AG (Germany) mRNA Vaccines & Therapeutics Sales Growth Rate (%)(2012-2017)
    Table Bayer AG (Germany) mRNA Vaccines & Therapeutics Sales Market Share (%) in Japan (2012-2017)
    Figure Bayer AG (Germany) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Japan (2012-2017)
    Table BioNTech (Germany) Basic Information List
    Table BioNTech (Germany) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Table BioNTech (Germany) mRNA Vaccines & Therapeutics Sales Growth Rate (%)(2012-2017)
    Table BioNTech (Germany) mRNA Vaccines & Therapeutics Sales Market Share (%) in Japan (2012-2017)
    Figure BioNTech (Germany) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Japan (2012-2017)
    Table Boehringer Ingelheim (Germany) Basic Information List
    Table Boehringer Ingelheim (Germany) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Table Boehringer Ingelheim (Germany) mRNA Vaccines & Therapeutics Sales Growth Rate (%)(2012-2017)
    Table Boehringer Ingelheim (Germany) mRNA Vaccines & Therapeutics Sales Market Share (%) in Japan (2012-2017)
    Figure Boehringer Ingelheim (Germany) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Japan (2012-2017)
    Table CRISPR Therapeutics (Switzerland) Basic Information List
    Table CRISPR Therapeutics (Switzerland) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Table CRISPR Therapeutics (Switzerland) mRNA Vaccines & Therapeutics Sales Growth Rate (%)(2012-2017)
    Table CRISPR Therapeutics (Switzerland) mRNA Vaccines & Therapeutics Sales Market Share (%) in Japan (2012-2017)
    Figure CRISPR Therapeutics (Switzerland) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Japan (2012-2017)
    Table CureVac (Germany) Basic Information List
    Table CureVac (Germany) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Table CureVac (Germany) mRNA Vaccines & Therapeutics Sales Growth Rate (%)(2012-2017)
    Table CureVac (Germany) mRNA Vaccines & Therapeutics Sales Market Share (%) in Japan (2012-2017)
    Figure CureVac (Germany) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Japan (2012-2017)
    Table ETheRNA immunotherapies (Belgium) Basic Information List
    Table ETheRNA immunotherapies (Belgium) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Table ETheRNA immunotherapies (Belgium) mRNA Vaccines & Therapeutics Sales Growth Rate (%)(2012-2017)
    Table ETheRNA immunotherapies (Belgium) mRNA Vaccines & Therapeutics Sales Market Share (%) in Japan (2012-2017)
    Figure ETheRNA immunotherapies (Belgium) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Japan (2012-2017)
    Table Ethris (Germany) Basic Information List
    Table Ethris (Germany) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Table Ethris (Germany) mRNA Vaccines & Therapeutics Sales Growth Rate (%)(2012-2017)
    Table Ethris (Germany) mRNA Vaccines & Therapeutics Sales Market Share (%) in Japan (2012-2017)
    Figure Ethris (Germany) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Japan (2012-2017)
    Table GlaxoSmithKline Vaccines (UK) Basic Information List
    Table GlaxoSmithKline Vaccines (UK) mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017)
    Table GlaxoSmithKline Vaccines (UK) mRNA Vaccines & Therapeutics Sales Growth Rate (%)(2012-2017)
    Table GlaxoSmithKline Vaccines (UK) mRNA Vaccines & Therapeutics Sales Market Share (%) in Japan (2012-2017)
    Figure GlaxoSmithKline Vaccines (UK) mRNA Vaccines & Therapeutics Revenue Market Share (%) in Japan (2012-2017)
    Table In-Cell-Art (France) Basic Information List
    Table Intellia Therapeutics (U.S.) Basic Information List
    Table Janssen (Belhium) Basic Information List
    Table Kernal Biologics (U.S.) Basic Information List
    Table MaxCyte (U.S.) Basic Information List
    Table Moderna Therapeutics (U.S.) Basic Information List
    Table Novartis (U.S.) Basic Information List
    Table PhaseRx (U.S.) Basic Information List
    Table Precision NanoSystems (Canada) Basic Information List
    Table RaNa Therapeutics (U.S.) Basic Information List
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of mRNA Vaccines & Therapeutics
    Figure Manufacturing Process Analysis of mRNA Vaccines & Therapeutics
    Figure mRNA Vaccines & Therapeutics Industrial Chain Analysis
    Table Raw Materials Sources of mRNA Vaccines & Therapeutics Major Players/Manufacturers in 2016
    Table Major Buyers of mRNA Vaccines & Therapeutics
    Table Distributors/Traders List
    Figure Japan mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
    Figure Japan mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Japan mRNA Vaccines & Therapeutics Price (USD/Unit) Trend Forecast (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Price (USD/Unit) Trend Forecast (2017-2022)
    Table Japan mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Type (2017-2022)
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Type (2017-2022)
    Figure Japan mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Type (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Type (2017-2022)
    Figure Japan mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Type in 2017
    Figure Global mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Type in 2017
    Table Japan mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Application (2017-2022)
    Figure Japan mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Japan mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Application in 2017
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Application (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Application (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Application in 2017
    Table Japan mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Regions (2017-2022)
    Table Japan mRNA Vaccines & Therapeutics Sales Volume Share Forecast by Regions (2017-2022)
    Figure Japan mRNA Vaccines & Therapeutics Sales Volume Share Forecast by Regions (2017-2022)
    Table Global mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Regions (2017-2022)
    Table Global mRNA Vaccines & Therapeutics Sales Volume Share Forecast by Regions (2017-2022)
    Figure Global mRNA Vaccines & Therapeutics Sales Volume Share Forecast by Regions (2017-2022)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

 



To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global automotive relay market is anticipated to reach USD 12 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising need for high-frequency signals in automotive industry is expected to drive demand. These relays enhance driv

Read More...

Global gas sensors market is expected to reach USD 2,512.4 million by 2020, as per a new research report by Radiant Insights, Inc. High adoption rate of wireless and smart gas sensor technology coupled with escalating demand from end-use industries s

Read More...

Global advanced energy storage systems market size is anticipated to be valued at USD 24.8 billion by 2022, as per a new research report by Radiant Insights, Inc. Increasing energy consumption coupled with strong energy demand for industrial, commerc

Read More...

Global agricultural films market size is anticipated to reach USD 10.5 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to raise agricultural productivity, in order to meet surplus demand by growing population i

Read More...

Global FPGA market is anticipated to be valued at USD 9,882.5 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing demand for customized IC’s is expected to drive the demand. Customized IC’s helps manufacturers to mo

Read More...
Choose License Type
Single User - US $3085
Multi User - US $6170
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify